Rays Power Infra announced closure of INR 127 Crore Equity Capital Fund Raise - Second Act Awards 2026 Celebrate Courage, Reinvention and Meaningful New Beginnings Meenakashi Lekhi attended the Mumbai event as Chief Guest as entrepreneurs, artists and changemakers were honoured for rewriting their life stories - Prestigious Asia’s Modern Hero Award 2026 Dr. Nilesh Potdar Honoured with Asia’s Modern Hero Award 2026 - Maharashtra’s Culture Comes Alive in Berlin as ‘Ganpati Bappa Morya’ Echoes Across the City - Matrimonial Dispute Widens Into Parallel Legal Proceedings Across Delhi and Uttar Pradesh A June 2025 complaint by Ayush Gupta preceded Nikita Jaiswal’s September 2025 Kanpur FIR; subsequent proceedings have brought documentary evidence, competing allegations and judicial scrutiny into the public record - Five-Year-Old Boy with Relapsed Leukemia is Cancer-Free after Haploidentical Bone Marrow Transplant at Kokilaben Hospital, Navi Mumbai - Orient Cables (India) Limited Announced its ₹5,520.00 million Initial Public Offering (IPO) to open on September 25, 2026 Price Band fixed at ₹258 to ₹272 per equity share of face value of ₹1 each - AceVector Limited Announced it's Initial Public Offer (IPO) of Equity Shares to open on September 25, 2026, Price Band is fixed at ₹ 30 to ₹ 32 per equity share of face value of ₹ 1 each - Moneyview Limited announced its Initial public offering (IPO) to open on Thursday, September 24, 2026 Price Band fixed at ₹32 per equity share of face value ₹1 each to ₹34 per equity share of the face value of ₹1 each - Moneyview Limited announced it's Initial public offering (IPO) to open on Thursday, September 24, 2026 Price Band fixed at ₹32 per equity share of face value ₹1 each to ₹34 per equity share of the face value of ₹1 each - BVG India awarded contract of Chambal Riverfront to Develop a Destination for Sustainable Urban Living and Tourism

Below 5 years babies to breathe easy with nebulisers having nasal aspirator function, Effective for clear nasal tract and both upper & lower airway treatment

Mumbai, Sep 07 2020 (GNI): Nasal congestion due to mucus secretion is a common issue among infants. However, despite the great advances made in medical technology, in majority of cases, the mucus formed is removed manually by parents, causing great discomfort to the child.

OMRON Healthcare India, the global leader in the field of clinically proven & innovative medical equipment for home health monitoring and therapy, backs the utility of nasal aspirator to help parents effectively manage such situations. “A nasal aspirator is gentle, more efficient, less invasive, and easier to use in comparison to manual methods including bulb syringe or saline drops. It’s very helpful in making the nasal tract clean for the baby which plays an important role in improving the eating and sleeping habits thus reducing the risk of developing other infections,” says Rohit Saini, GM-Sales and Marketing, OMRON Healthcare India.

The company has recently unveiled “DuoBaby”, a nebuliser cum nasal aspirator designed especially for new-born babies. The 2-in-1 device is India’s first-of-its-kind drug delivery device exclusively designed for treating respiratory ailments in babies aged between 0-5 years.

Accompanied with a full suite of accessories, the DuoBaby eases baby’s cough and nasal blockages, while treating upper and lower airway respiratory conditions. It is a path-breaking offering in the field of drug delivery devices for treatment of respiratory ailments (ranging from minor flus to asthmas and bronchitis) in babies.

As a responsible & discerning medical devices maker, OMRON identifies it as one of the most pertinent healthcare needs of the society. As per Rohit, “Along with the key value proposition, we have tried to bring in utmost convenience and utility so that the parents can reduce their visits to clinics decrease the chances of Covid exposure.”

About OMRON Healthcare India

Established in 2010, OMRON Healthcare India is a key player in the health care segment providing innovative medical technologies for Monitoring and Therapy. Equipped with OMRON’s competent “Bio-information Sensing” the portfolio comprises of home healthcare products such as blood pressure monitors, respiratory therapy devices, body fat monitors, digital thermometers, pain management devices, etc. OMRON Healthcare was the first to introduce manual and digital blood pressure units to the home healthcare market in the world. Today, OMRON has the highest market share in the home-use digital BP monitor in India and across the globe.

OMRON Duo Baby is available at OMRON Brandshop:

https://www.omronbrandshop.com/home-care/nebulizers/duobaby/

Be the first to comment on "Below 5 years babies to breathe easy with nebulisers having nasal aspirator function, Effective for clear nasal tract and both upper & lower airway treatment"

Leave a comment

Your email address will not be published.


*